AbSci is a biotechnology company that specializes in protein production and optimization. The company was founded in 2011 by Sean McClain and is based in Eugene, Oregon. AbSci's proprietary platform, SoluPro, enables the production of complex proteins at a lower cost and in a shorter time frame than traditional methods. The platform has applications in drug discovery, biomanufacturing, and industrial enzymes. AbSci has partnerships with companies such as Astellas Pharma and Alpha Cancer Technologies.